Democratic U.S. Senate candidate Abdul El-Sayed leaned on his medical training at a Michigan State University rally to argue the government should stay out of decisions about sex-change procedures for children, even as federal regulators and foreign health agencies move in the opposite direction.
El-Sayed, a former Detroit Health Department head now running for Michigan's open Senate seat, responded to a student's question about "protecting sex changes" at the Friday event by repeatedly invoking his own education. He told the crowd he attended "a whole a** medical school" and that fellow graduates completed residencies, fellowships, and board exams qualifying them to make clinical decisions without government interference.
The argument placed El-Sayed squarely against the Trump administration's recent push to restrict minors' access to hormone therapy and surgical procedures, and against a growing body of international medical opinion that has pulled back from the same treatments El-Sayed wants to shield from regulation.
At the rally, El-Sayed cast the issue in libertarian terms, telling attendees that medical decisions "ought to be held between a patient, and or their parents if they're under the age of 18, and their doctor. That's it." He added that he does not believe "the government gets to have a say about what healthcare is provided in what circumstances and why."
He went further, invoking the Right to Try Act, a law backed by conservatives that lets terminally ill patients access experimental drugs not yet approved by the FDA after exhausting other options. Fox News Digital reported that El-Sayed used the law to argue conservatives already agree with his principle.
"So they agree that the decision about healthcare ought to be between the person and their provider. That's it. So let's use that standard, and keep to that standard, and make sure the government doesn't have the ability to tell you what you can or cannot do with your own life."
The comparison is a stretch. The Right to Try Act applies to patients facing terminal diagnoses who have no remaining approved treatments. It was designed to remove bureaucratic barriers for people running out of time, not to establish a blanket principle that any medical intervention a provider offers is beyond government review. Applying that framework to elective procedures on minors, whose brains and bodies are still developing, conflates two fundamentally different situations.
El-Sayed also acknowledged "a lot of disinformation" around the issue but offered no specifics about which claims he considers false. He said the decision belongs "in that clinical room between a patient and a provider" and called that "the center we should engage on."
El-Sayed's campaign has made his medical background a centerpiece of his pitch. His spokesperson, Roxie Richner, told reporters he "earned a medical doctorate from Columbia University and a doctorate in public health from Oxford University" and "has earned the right to be called 'doctor' twice over."
Richner also cited his public health record, including "the elimination of millions of dollars in medical debt, increased access to Narcan, and the creation of a state-of-the-art air quality monitoring network." El-Sayed's campaign has promoted the idea that he would be the first doctor to serve as a Democratic senator in 50 years.
But Fox News Digital has previously reported that El-Sayed has never held a medical license in Michigan or New York. Two Ivy League degrees and a public health résumé are genuine accomplishments. They are not the same thing as practicing medicine. A candidate who builds his authority on clinical expertise while lacking the license to actually treat patients in his own state is asking voters to accept credentials that stop short of the finish line.
El-Sayed defeated the candidate backed by Senate Democratic leadership in the primary, giving progressives a foothold in a critical swing state. His rally remarks suggest he intends to run hard to the left on transgender medical policy heading into the general election.
El-Sayed's "leave it to the doctors" argument landed the same week the Department of Justice announced that Mount Sinai had joined Texas Children's Hospital, Cleveland Clinic Foundation, and Connecticut Children's Hospital in agreeing to halt sex-change procedures for children after negotiations with the Trump administration. Four major medical institutions, not fringe clinics, decided to stop performing these procedures on minors.
The Federal Trade Commission has gone even further. The FTC and multiple states filed a lawsuit against the World Professional Association for Transgender Health, or WPATH, the organization whose clinical guidelines are used by leading medical groups including the American Academy of Pediatrics. The FTC accused WPATH of misleading parents about "medical consensus and medical necessity, as well as the safety and effectiveness" of sex-change procedures.
Among the side effects the FTC says WPATH failed to disclose: incontinence, erectile pain, mood disturbances, pelvic pain, and vaginal pain stemming from cross-sex hormones. These are not trivial risks. They are life-altering complications being imposed on patients who, in many cases, cannot legally sign a contract, buy a beer, or vote.
El-Sayed's position assumes the medical establishment has reached a settled, trustworthy consensus on these procedures. The FTC's lawsuit alleges the opposite, that the very organization setting the clinical standards deceived families about what the evidence actually shows.
Meanwhile, Republican Mike Rogers has been courting Democratic defectors in the Michigan Senate race, and El-Sayed's aggressive stance on this issue may hand his opponent new ammunition with moderate voters.
The international trend cuts against El-Sayed's framing as well. England's National Health Service paused cross-sex hormones for 16- and 17-year-olds in March after concluding that the research supporting the treatment was "really weak." The NHS already had a ban in place restricting children under 16 from receiving sex-change hormones.
England's system is government-run healthcare, the kind of single-payer model many progressives admire. When even that system determines the evidence is too thin to justify these treatments for teenagers, a candidate who waves away safety concerns by citing his own diplomas is not making a medical argument. He is making a political one.
El-Sayed's campaign has already drawn scrutiny on other fronts. He deleted a controversial 9/11 post under pressure from party leaders, and his remarks about Usha Vance drew backlash from Indian-American and women voters. A pattern is forming: El-Sayed takes a provocative position, leans on his credentials or progressive bona fides, and then his campaign cleans up the fallout.
El-Sayed told the Michigan State University crowd that there is "a lot of disinformation" around transgender healthcare. He is right about that, but the disinformation may not be coming from the direction he thinks. The FTC alleges the leading professional body in the field misled families. Four major hospitals agreed to stop performing these procedures on children. A foreign national health service called the supporting research "really weak."
Against all of that, El-Sayed's answer is: trust the doctors. Trust the same clinical establishment whose guidelines are now the subject of a federal lawsuit. Trust the same consensus that hospitals backed away from under legal scrutiny. And trust him, a candidate who went to medical school but never obtained a license to practice in the state he wants to represent.
The cross-party defections already emerging in the Michigan race suggest that voters may not find that answer sufficient. El-Sayed is betting that progressive energy on transgender issues will carry him through a general election in a swing state. That bet requires Michigan voters to ignore a growing pile of evidence that the medical establishment he invokes is fracturing on this very question.
Diplomas on a wall do not settle a scientific debate, especially when the institutions that granted them are still arguing about the answer.
